These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery. Jiang T; Zhang Z; Zhang Y; Lv H; Zhou J; Li C; Hou L; Zhang Q Biomaterials; 2012 Dec; 33(36):9246-58. PubMed ID: 23031530 [TBL] [Abstract][Full Text] [Related]
3. Lysosome-Independent Intracellular Drug/Gene Codelivery by Lipoprotein-Derived Nanovector for Synergistic Apoptosis-Inducing Cancer-Targeted Therapy. Wang W; Chen K; Su Y; Zhang J; Li M; Zhou J Biomacromolecules; 2018 Feb; 19(2):438-448. PubMed ID: 29334216 [TBL] [Abstract][Full Text] [Related]
4. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells. Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697 [TBL] [Abstract][Full Text] [Related]
5. Natural Particulates Inspired Specific-Targeted Codelivery of siRNA and Paclitaxel for Collaborative Antitumor Therapy. Wang R; Zhao Z; Han Y; Hu S; Opoku-Damoah Y; Zhou J; Yin L; Ding Y Mol Pharm; 2017 Sep; 14(9):2999-3012. PubMed ID: 28753317 [TBL] [Abstract][Full Text] [Related]
6. Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment. Zhang Z; Qian H; Huang J; Sha H; Zhang H; Yu L; Liu B; Hua D; Qian X Int J Nanomedicine; 2018; 13():4961-4975. PubMed ID: 30214200 [TBL] [Abstract][Full Text] [Related]
7. Targeted Biomimetic Nanoparticles for Synergistic Combination Chemotherapy of Paclitaxel and Doxorubicin. Rui M; Xin Y; Li R; Ge Y; Feng C; Xu X Mol Pharm; 2017 Jan; 14(1):107-123. PubMed ID: 27982602 [TBL] [Abstract][Full Text] [Related]
8. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy. Ding Y; Wang W; Feng M; Wang Y; Zhou J; Ding X; Zhou X; Liu C; Wang R; Zhang Q Biomaterials; 2012 Dec; 33(34):8893-905. PubMed ID: 22979990 [TBL] [Abstract][Full Text] [Related]
9. Cell penetrating peptides functionalized gambogic acid-nanostructured lipid carrier for cancer treatment. Huang R; Li J; Kebebe D; Wu Y; Zhang B; Liu Z Drug Deliv; 2018 Nov; 25(1):757-765. PubMed ID: 29528244 [TBL] [Abstract][Full Text] [Related]
10. Biomimetic HDL nanoparticle mediated tumor targeted delivery of indocyanine green for enhanced photodynamic therapy. Wang Y; Wang C; Ding Y; Li J; Li M; Liang X; Zhou J; Wang W Colloids Surf B Biointerfaces; 2016 Dec; 148():533-540. PubMed ID: 27690242 [TBL] [Abstract][Full Text] [Related]
11. A novel redox/pH dual-responsive and hyaluronic acid-decorated multifunctional magnetic complex micelle for targeted gambogic acid delivery for the treatment of triple negative breast cancer. Sang MM; Liu FL; Wang Y; Luo RJ; Huan XX; Han LF; Zhang ZT; Feng F; Qu W; Liu W; Zheng F Drug Deliv; 2018 Nov; 25(1):1846-1857. PubMed ID: 30334478 [TBL] [Abstract][Full Text] [Related]
12. Direct cytosolic siRNA delivery by reconstituted high density lipoprotein for target-specific therapy of tumor angiogenesis. Ding Y; Wang Y; Zhou J; Gu X; Wang W; Liu C; Bao X; Wang C; Li Y; Zhang Q Biomaterials; 2014 Aug; 35(25):7214-27. PubMed ID: 24875759 [TBL] [Abstract][Full Text] [Related]
13. Gambogic acid-loaded PEG-PCL nanoparticles act as an effective antitumor agent against gastric cancer. Zhang D; Zou Z; Ren W; Qian H; Cheng Q; Ji L; Liu B; Liu Q Pharm Dev Technol; 2018 Jan; 23(1):33-40. PubMed ID: 29069711 [TBL] [Abstract][Full Text] [Related]
14. A dual-targeting drug co-delivery system for tumor chemo- and gene combined therapy. Zhang F; Li M; Su Y; Zhou J; Wang W Mater Sci Eng C Mater Biol Appl; 2016 Jul; 64():208-218. PubMed ID: 27127046 [TBL] [Abstract][Full Text] [Related]
15. Mimic Lipoproteins Responsive to Intratumoral pH and Allosteric Enzyme for Efficient Tumor Therapy. Li J; Wang H; Xu J; Wu S; Han M; Li J; Wang Q; Ge Z ACS Appl Mater Interfaces; 2022 Jan; 14(1):404-416. PubMed ID: 34962752 [TBL] [Abstract][Full Text] [Related]
16. Antitumor Activity of Thermosensitive Hydrogels Packaging Gambogic Acid Nanoparticles and Tumor-Penetrating Peptide iRGD Against Gastric Cancer. Zhang D; Chu Y; Qian H; Qian L; Shao J; Xu Q; Yu L; Li R; Zhang Q; Wu F; Liu B; Liu Q Int J Nanomedicine; 2020; 15():735-747. PubMed ID: 32099362 [TBL] [Abstract][Full Text] [Related]
17. Peptide-Targeted High-Density Lipoprotein Nanoparticles for Combinatorial Treatment against Metastatic Breast Cancer. Jiang C; Wang X; Teng B; Wang Z; Li F; Zhao Y; Guo Y; Zeng Q ACS Appl Mater Interfaces; 2021 Aug; 13(30):35248-35265. PubMed ID: 34284582 [TBL] [Abstract][Full Text] [Related]
18. Nanomedicine-based combination of gambogic acid and retinoic acid chlorochalcone for enhanced anticancer efficacy in osteosarcoma. Liu L; Qi XJ; Zhong ZK; Zhang EN Biomed Pharmacother; 2016 Oct; 83():79-84. PubMed ID: 27470553 [TBL] [Abstract][Full Text] [Related]
19. Gambogic acid-loaded pH-sensitive mixed micelles for overcoming breast cancer resistance. Wang S; Yang Y; Wang Y; Chen M Int J Pharm; 2015 Nov; 495(2):840-8. PubMed ID: 26407923 [TBL] [Abstract][Full Text] [Related]
20. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy. Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]